Acquired angioedema: a new target for rituximab?

Haematologica. 2004 Aug;89(8):ELT13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angioedema / blood
  • Angioedema / drug therapy*
  • Angioedema / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Complement Activation
  • Complement C1 / deficiency
  • Humans
  • Immunologic Factors / therapeutic use*
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Complement C1
  • Immunologic Factors
  • Rituximab